Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry. - Wikidata - wikimedia - TriplyDB

Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry.

Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry.

http://www.wikidata.org/entity/Q35410804

about

Pathobiology of pulmonary arterial hypertension and right ventricular failure Breaking Down the Barriers: Why the Delay in Referral for Pulmonary Arterial Hypertension?World Health Organization Group I Pulmonary Hypertension: Epidemiology and Pathophysiology.Derivation of a screening tool to identify patients with right ventricular dysfunction or tricuspid regurgitation after negative computerized tomographic pulmonary angiography of the chest.Pulmonary arterial hypertension: Specialists' knowledge, practices, and attitudes of genetic counseling and genetic testing in the USA Chronic pulmonary artery dissection associated with pulmonary arterial hypertension Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Perioperative management in patients with pulmonary hypertension.Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates Pulmonary hypertension surveillance: United States, 2001 to 2010 Information experiences and needs in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.Exercise intolerance in pulmonary arterial hypertension Perceptions of received information, social support, and coping in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.Significance of main pulmonary artery dilation on imaging studies.Sex and haemodynamics in pulmonary arterial hypertension.Predicting pulmonary hypertension with standard computed tomography pulmonary angiography Determinants of an elevated pulmonary arterial pressure in patients with pulmonary arterial hypertension Where do we go from here? Reappraising the data on anticoagulation in pulmonary arterial hypertension.Sex and menopause differences in response to tadalafil: 6-minute walk distance and time to clinical worsening.Time from symptoms to definitive diagnosis of idiopathic pulmonary arterial hypertension: The delay study Pulmonary hypertension in Saudi Arabia: A single center experience.The Characteristics of Treated Pulmonary Arterial Hypertension Patients in Ontario.Provider recognition and response to echocardiographic findings indicating pulmonary hypertension in the Veterans affairs medical center population.Sleep disordered breathing in group 1 pulmonary arterial hypertension.Breath analysis in pulmonary arterial hypertension.Validity of the surface electrocardiogram criteria for right ventricular hypertrophy: the MESA-RV Study (Multi-Ethnic Study of Atherosclerosis-Right Ventricle)Pharmacologic management of perioperative pulmonary hypertension.CT-based pulmonary artery measurements for the assessment of pulmonary hypertension.The other pulmonary hypertension: heart failure with preserved ejection fraction.Cluster analysis of symptoms in pulmonary arterial hypertension: a pilot study.Combination pharmacotherapy in the treatment of pulmonary arterial hypertension: continuing education article.Pulmonary hypertension and breathlessness: is it a combination we can ignore?The role of nuclear imaging in pulmonary hypertension.Learning a Comorbidity-Driven Taxonomy of Pediatric Pulmonary Hypertension.Harmonic subtraction for evaluating right ventricle ejection fraction from planar equilibrium radionuclide angiography.Diagnosis, Treatment, and Clinical Management of Pulmonary Arterial Hypertension in the Contemporary Era: A Review.A virtual community: concerns of patients with pulmonary hypertension.Characteristics and survival of adult Swedish PAH and CTEPH patients 2000-2014.A binational registry of adults with pulmonary arterial hypertension complicating congenital heart disease.Building a pulmonary vascular service: the 12-year experience and outcomes of the Auckland pulmonary arterial hypertension clinic.Sleep disturbance, symptoms, psychological distress, and health-related quality of life in pulmonary arterial hypertension.

P2860

Q26821779-D1E63AAB-9469-42F2-9FFE-5FE0D6B37601 Q28078660-A4D61235-464D-4060-85B7-5E3945F10B42 Q30248878-B7DF98B7-2B56-4A3F-8BAE-A36C5E74FA8E Q30411629-1D1C7723-3D1B-4F7B-BC10-8FB2A05B8879 Q33788468-FA489297-BF21-4678-AD4E-7E16BFA23B0A Q33806071-D3CBA7FD-25DA-445D-B7C4-14115900B057 Q33965837-3BC94719-3CC2-4B98-AA1D-4DCB534790AB Q33965904-087FC0F3-D202-48A5-A0AA-59824EF66C57 Q34004369-88957DEC-E715-4A9D-9FCF-485B8E60DBAD Q34114549-010501B3-F824-4D2E-AFB2-2C9686806BA9 Q34284458-4441A86F-7C9E-4362-9B54-5E08D878B952 Q34421411-6792BDDF-B7E0-4ACD-9975-AC3F1201E5C0 Q34984664-8540D6E1-322F-4C42-B35C-1BEF4C3FF2D5 Q35116055-AC9AF64D-163F-49B3-AD3D-7AB5FACD8F79 Q35597770-84F79E06-586B-4030-9B4E-FA2702E53EDB Q35825326-658A34D3-4707-40C1-B201-28A8CC494228 Q36013002-3ED67693-32AB-4897-A807-E15F2A864EDC Q36352106-61EB01CA-D435-4DCD-9854-568B3B0316EE Q36810855-62CA744E-E3C8-4A06-8264-127F6F25A693 Q36886438-C9F9391E-1674-4AA2-98DF-F0A1A20AF74C Q36996773-51CA8977-F57D-4461-9149-DE8F8171B33C Q37133823-E6FA87FE-32CC-4F02-8031-D04786AC34AA Q37590184-EAC57F14-34C4-480D-97CF-5C647F5CB07B Q37615204-741864E6-5168-4677-BC87-7B85E36CD662 Q37620281-77156F26-680E-4D0C-83AC-0A483ED42B22 Q37695550-E83FA268-58FC-4538-A9C6-BF020A3A1C70 Q37700987-50BF9B85-85C1-46B1-9B3D-E114A1599A8A Q37898743-DC70F2DE-24BD-4694-B81E-63E1C2A88243 Q37987390-8EEBD614-2CC0-4FD9-9263-9FFCE0CB00A9 Q38082752-435014DD-D271-4C2C-959F-DAA9535DA69E Q38175197-2ED03435-B9C4-4DAF-8F79-D1111639B48C Q38243749-CC5E0A01-790A-4CAD-AF7B-0C4D713F3B32 Q38727072-4977DC9A-8B4F-43D6-9520-782B1BE10BC1 Q38779513-2D776252-2666-42AF-9171-A16EEC7E6335 Q39010196-E7B19B08-EC96-4564-A911-6B391D4909AE Q39531465-432F718C-174C-44A2-8417-64C98A89F9AD Q39794040-FA837B83-3E5D-4A35-B045-FC7A2FFC8254 Q40901955-5766DAE4-0A33-425E-99FF-C68E868A161A Q43421643-B5B97F9F-0E2E-413A-95B0-F60821D0C6E4 Q43471329-6F8AD594-CDD8-4E81-ADE4-E300EFE405AA

P2860

Delay in recognition of pulmonary arterial hypertension: factors identified from the REVEAL Registry.

http://www.wikidata.org/entity/Q35410804

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Delay in recognition of pulmon ...... fied from the REVEAL Registry.

@ast

Delay in recognition of pulmon ...... fied from the REVEAL Registry.

@en

type

label

Delay in recognition of pulmon ...... fied from the REVEAL Registry.

@ast

Delay in recognition of pulmon ...... fied from the REVEAL Registry.

@en

prefLabel

Delay in recognition of pulmon ...... fied from the REVEAL Registry.

@ast

Delay in recognition of pulmon ...... fied from the REVEAL Registry.

@en

P1433

Q35410804-92CB724C-F643-4E37-86D4-8D6A3214340B

P1476

Q35410804-144A67A6-8C33-49AA-B44F-A5C2CC3D883B

P2093

Q35410804-2FF77107-5C98-49A2-BD41-41B075C4A4FE

Q35410804-8C55CB6A-F2AE-43B3-8B18-CFA350C3CC57

Q35410804-96F37799-5633-4436-B17E-123532EFD0BC

Q35410804-AA39BC34-6D6E-4B9A-B647-E802799418E7

Q35410804-AC4C0625-9D66-4F8F-943B-EB0F6488F9F1

Q35410804-B6AA3FB6-4853-4996-A5D7-72229C13E2C4

Q35410804-C7636A78-F140-492A-8C72-7E47BC547DF0

Q35410804-E7465F58-4FEE-431C-9B5D-2EA1C0C01AFC

Q35410804-FBA584FF-FE91-4D7A-AA14-545F737B0565

Q35410804-FC757FC0-4FED-4DD7-A8F1-C80BD46B80F5

P2860

Q35410804-03523FB1-96A3-4112-B392-E8449F4CFA92

Q35410804-1246C487-E612-45FC-9970-3F73CFF2E021

Q35410804-21B5AC04-8AF2-44B4-A09D-2A5ABDC67A4C

Q35410804-29DB1848-B861-4884-A8FB-E913F4B45EFD

Q35410804-2FC4A4CF-4533-4AE7-AE20-78BC464E96E7

Q35410804-322E0A39-3838-47F8-9226-328B1F9F88D1

Q35410804-40E3F8FA-22F3-4404-9A44-775CB2439B0F

Q35410804-428FEFB2-223F-4AD4-8771-A71D6027CD50

Q35410804-4934DCF1-92F9-45D6-A7EE-A1B96C54D439

Q35410804-5BFE4849-5512-4574-BDC4-40B1773F721D

P304

Q35410804-F14EE5D9-A9F4-4470-9821-CB2F06BA3A7A

P31

Q35410804-7EF3465E-C9DD-4CC6-A3A7-ECB4B7E5E234

P356

Q35410804-04D57B81-C72D-4407-9B62-4314DED9B9D2

P407

Q35410804-4D65E4E2-F65C-49D4-A042-923FB4107F4F

P433

Q35410804-458AB2BD-9B83-422A-A7E1-3709A49A93B8

P478

Q35410804-17142B59-5248-43BB-A3F0-8D0F9B4CB92B

P50

Q35410804-66412290-B2BB-4158-A849-D3C8F29DBEC2

Q35410804-94FFA4E1-AE7D-4290-BA2A-431C3A793C5C

P577

Q35410804-E68AD414-F99A-49A8-80C2-8869F8509B3A

P5875

Q35410804-DC3A1606-F72D-4E62-AA95-91FF4E8839B3

P698

Q35410804-324D0D26-0C2D-4D2A-B086-D8B3E61F3390

P932

Q35410804-13699851-BED0-401A-878A-215C76DEE133

P356

P1433

P1476

Delay in recognition of pulmon ...... ified from the REVEAL Registry

@en

P2093

Adaani E Frost

http://www.w3.org/2001/XMLSchema#string

C Gregory Elliott

http://www.w3.org/2001/XMLSchema#string

Darren Taichman

http://www.w3.org/2001/XMLSchema#string

Dave P Miller

http://www.w3.org/2001/XMLSchema#string

Hubert Chen

http://www.w3.org/2001/XMLSchema#string

Kathy Feldkircher

http://www.w3.org/2001/XMLSchema#string

Lynette M Brown

http://www.w3.org/2001/XMLSchema#string

Michael D McGoon

http://www.w3.org/2001/XMLSchema#string

Michelle Turner

http://www.w3.org/2001/XMLSchema#string

Scott Halpern

http://www.w3.org/2001/XMLSchema#string

P2860

Updated clinical classification of pulmonary hypertension.

Epidemiology of pulmonary hypertension: new data from the Swiss registry.

Primary pulmonary hypertension. A national prospective study.

Pulmonary arterial hypertension in France: results from a national registry.

Sildenafil citrate therapy for pulmonary arterial hypertension.

ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American Coll

Diagnosis and assessment of pulmonary arterial hypertension.

Gender bias in cardiovascular testing persists after adjustment for presenting characteristics and cardiac risk.

Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient.

The 2007 GOLD Guidelines: a comprehensive care framework.

P304

19-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.10-1166

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

140

http://www.w3.org/2001/XMLSchema#string

P50

Harrison W Farber

Theodore G. Liou

P577

2011-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50363762

http://www.w3.org/2001/XMLSchema#string

P698

21393391

http://www.w3.org/2001/XMLSchema#string

P932

3198486

http://www.w3.org/2001/XMLSchema#string